{"id":16003,"date":"2021-08-04T12:42:58","date_gmt":"2021-08-04T11:42:58","guid":{"rendered":"https:\/\/psychedelichealth.co.uk\/?p=16003"},"modified":"2021-08-04T12:48:02","modified_gmt":"2021-08-04T11:48:02","slug":"psilothera-quantum-technology-drug-development","status":"publish","type":"post","link":"https:\/\/psychedelichealth.co.uk\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/","title":{"rendered":"PsiloThera launches quantum technology drug development programme"},"content":{"rendered":"

A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.<\/span><\/h3>\n

PsiloThera<\/a>, a psychedelic healthcare innovation and life sciences company developing psilocybin-based drugs and therapies, has announced the launch of its Quantum Technology Drug Development Programme – a technology that could help solve a number of problems in both drug discovery and drug development.<\/span><\/p>\n

The company\u2019s focus is on the treatment of indications such as depression, anxiety, post-traumatic stress disorder (PTSD<\/a>), eating disorders and addictions, as well as cognitive diseases and neurological disorders such as Alzheimer\u2019s disease, dementia and autism.<\/p>\n

Innovation in drug development<\/span><\/h3>\n

The company\u2019s <\/span>specialised treatment programmes will provide care for veterans, first responders and patients with treatment-resistant mental illnesses. The company aims to deploy its quantum technology programme in order to shorten drug development time.<\/p>\n

PsiloThera CEO, John Atanasio said: \u201cPsiloThera is among the first companies focused on developing novel therapeutics by deploying quantum technology that can collect and send materials through organic devices. PsiloThera’s strategy is to have its products lead the future of energy-based nutrients and medication delivery systems.<\/p>\n

“Quantum technology may lead to advances that could ultimately change the way that humans digest supplements, medications and nutrients. Our Quantum Technology Advisors projects that the technology projects to deliver significant improvements in areas of pharmaceutical dispensing issues and adverse effects.<\/p>\n

“Quantum Technology may\u00a0lead to significant reductions in drug development time and costs, giving PsiloThera a possible major competitive advantage if that were to prove true.\u201d<\/p>\n

The Journal of American Medical Association<\/em><\/a> reported in a 2020 study that treatment of psilocybin works better than usual anti-depressant medications. PsiloThera’s vertical business model includes fungi cultivation, Research & Development, drug development, a telehealth platform and PsiloThera Treatment Centres.<\/p>\n","protected":false},"excerpt":{"rendered":"

The company aims to deploy its quantum technology programme in order to shorten drug development time.<\/p>\n","protected":false},"author":20,"featured_media":16005,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_cbd_carousel_blocks":"[]","content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[215],"tags":[222,48,224,223,221],"yoast_head":"\nPsiloThera launches quantum technology drug development programme<\/title>\n<meta name=\"description\" content=\"A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PsiloThera launches quantum technology drug development programme\" \/>\n<meta property=\"og:description\" content=\"A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Psychedelic Health\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-04T11:42:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-04T11:48:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/34.142.66.208\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stephanie Price\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/steph_jprice\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stephanie Price\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/\",\"url\":\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/\",\"name\":\"PsiloThera launches quantum technology drug development programme\",\"isPartOf\":{\"@id\":\"https:\/\/34.142.66.208\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg\",\"datePublished\":\"2021-08-04T11:42:58+00:00\",\"dateModified\":\"2021-08-04T11:48:02+00:00\",\"author\":{\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\"},\"description\":\"A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.\",\"breadcrumb\":{\"@id\":\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#primaryimage\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg\",\"width\":1200,\"height\":800,\"caption\":\"PsiloThera launches quantum technology drug development programme\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/34.142.66.208\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PsiloThera launches quantum technology drug development programme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/34.142.66.208\/#website\",\"url\":\"https:\/\/34.142.66.208\/\",\"name\":\"Psychedelic Health\",\"description\":\"News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/34.142.66.208\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\",\"name\":\"Stephanie Price\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"caption\":\"Stephanie Price\"},\"description\":\"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \\\"Medical Cannabis Explained\\\".\",\"sameAs\":[\"https:\/\/psychedelichealth.co.uk\",\"https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice\"],\"url\":\"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PsiloThera launches quantum technology drug development programme","description":"A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/","og_locale":"en_GB","og_type":"article","og_title":"PsiloThera launches quantum technology drug development programme","og_description":"A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.","og_url":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/","og_site_name":"Psychedelic Health","article_publisher":"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","article_published_time":"2021-08-04T11:42:58+00:00","article_modified_time":"2021-08-04T11:48:02+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/34.142.66.208\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg","type":"image\/jpeg"}],"author":"Stephanie Price","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/steph_jprice","twitter_misc":{"Written by":"Stephanie Price","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/","url":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/","name":"PsiloThera launches quantum technology drug development programme","isPartOf":{"@id":"https:\/\/34.142.66.208\/#website"},"primaryImageOfPage":{"@id":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg","datePublished":"2021-08-04T11:42:58+00:00","dateModified":"2021-08-04T11:48:02+00:00","author":{"@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12"},"description":"A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.","breadcrumb":{"@id":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#primaryimage","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/quantumpsilo.jpg","width":1200,"height":800,"caption":"PsiloThera launches quantum technology drug development programme"},{"@type":"BreadcrumbList","@id":"https:\/\/34.142.66.208\/2021\/08\/04\/psilothera-quantum-technology-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/34.142.66.208\/"},{"@type":"ListItem","position":2,"name":"PsiloThera launches quantum technology drug development programme"}]},{"@type":"WebSite","@id":"https:\/\/34.142.66.208\/#website","url":"https:\/\/34.142.66.208\/","name":"Psychedelic Health","description":"News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/34.142.66.208\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12","name":"Stephanie Price","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/image\/","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","caption":"Stephanie Price"},"description":"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \"Medical Cannabis Explained\".","sameAs":["https:\/\/psychedelichealth.co.uk","https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice"],"url":"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/16003"}],"collection":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/comments?post=16003"}],"version-history":[{"count":0,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/16003\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media\/16005"}],"wp:attachment":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media?parent=16003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/categories?post=16003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/tags?post=16003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}